The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Matt Hewitt - Craig-Hallum Capital Group LLC - Analyst
: Good afternoon. Thank you for taking the questions. Maybe just to understand the difference here, you're having this period of increased cancellations.
At the same time, you're announcing record bookings, and I'm just trying to match the two together. They seem to run counter to each other. If
you could provide a little bit more color on what you're seeing and hearing from customers?
Question: Matt Hewitt - Craig-Hallum Capital Group LLC - Analyst
: Got it. Thank you. Thanks for the help there. As far as your cadence, I didn't hear an update on your full year guidance. I'm not sure if that means
it's the same or whatnot, but how should we think about cadence or how -- revenues recover a little bit here in Q4 before the big step-up, it sounds
like we would see early in 2024 or what should we be thinking for Q4?
Question: Matt Hewitt - Craig-Hallum Capital Group LLC - Analyst
: Got it. And then as far as gross margins are concerned, historically, there was -- we've talked about -- you've talked about the mismatch between
the costs -- when you start a new trial or news service for customer versus when you get to book those. That doesn't appear to be the case here in
Q3 unless I'm misunderstanding something. It sounds like this is more because of the cancellations, yet you kept and rightfully so it sounds like
kept all your staff in place anticipating that rebound. Did I hear that correctly?
Question: Matt Hewitt - Craig-Hallum Capital Group LLC - Analyst
: Got it. And then maybe one more and I'll hop back in the queue, but I'm wondering if we could get an update on how the Italian lab is performing.
It's now been, I think, a couple of quarters since it was open for business, maybe (technical difficulty) to fill some of the opportunity there and how
-- what are your expectations for that as we look out?
Question: Matt Hewitt - Craig-Hallum Capital Group LLC - Analyst
: Got it. Thank you very much.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MARCH 16, 2023 / NTS, CSBR.OQ - Q3 2023 Champions Oncology Inc Earnings Call
| 
